Journal of Public Health Policy

, Volume 34, Issue 2, pp 272–287

Does India need an indigenous HPV vaccine and why?

  • Kaushik Bharati
  • Nirmal Kumar Ganguly
Original Article

DOI: 10.1057/jphp.2013.4

Cite this article as:
Bharati, K. & Ganguly, N. J Public Health Pol (2013) 34: 272. doi:10.1057/jphp.2013.4


Cervical cancer is the most common form of cancer in Indian women, causing high morbidity and mortality. Two effective and safe vaccines exist, but these remain out of reach of most people due to their high cost. It is imperative that an Human Papillomavirus (HPV) vaccine be affordable and cheap so that the target population can be vaccinated, to make a real impact in reducing the disease burden. We argue that in the long run India needs to develop and manufacture its own HPV vaccine in order to bridge this price gap. We also explore other strategies that can be adopted to increase the accessibility and affordability of this life-saving vaccine during the interim period.


IndiaHPV vaccinehealth policy

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Ltd 2013

Authors and Affiliations

  • Kaushik Bharati
    • 1
  • Nirmal Kumar Ganguly
    • 1
  1. 1.National Institute of Immunology, Aruna Asaf Ali MargNew DelhiIndia